¸Þµð¾÷

´ëÇк´¿ø Çѹ溴¿ø
Á¾ÇÕº´¿ø ³ëÀκ´¿ø
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹Á¤º¸
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ëºÐ¾ç¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
¸ÞµðÅå
´ëÇк´¿ø Á¾ÇÕº´¿ø Çѹ溴¿ø Ä¡°úº´¿ø ÇÑÀÇ¿ø ³ëÀÎÀü¹®º´¿ø º¸°Ç¼Ò
¼­¿ï ºÎ»ê ÀÎõ ´ë±¸ ´ëÀü ±¤ÁÖ ¿ï»ê °æ±â °­¿ø ÃæºÏ Ãæ³² °æºÏ °æ³² ÀüºÏ Àü³² Á¦ÁÖ ¼¼Á¾
Ä¡°ú ¾È°ú ÇǺΰú ¼ºÇü¿Ü°ú »êºÎÀΰú ºñ´¢±â°ú ¿Ü°ú ³»°ú Á¤Çü¿Ü°ú À̺ñÀÎÈÄ°ú ¼Ò¾Æ°ú ¾à±¹

¸ñ·Ï ¼öÁ¤ »èÁ¦

´ëÇÑÀ§Àå°ü¿Ü°úÇÐȸ Á¦1ȸ Ç׾Ͽ¬±¸ Çмú´ëȸ : 2023-09-02

ÃßõÇϱâ
¿¬¼ö°­Á À̹øÁÖ BEST
 

´ëÇÑÀ§Àå°ü¿Ü°úÇÐȸ Á¦1ȸ Ç׾Ͽ¬±¸ Çмú´ëȸ : 2023-09-02
±³À°ÀÏÀÚ : 2023-09-02
±³À°Àå¼Ò : Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦

±³À°ÁÖÁ¦ : ´ëÇÑÀ§Àå°ü¿Ü°úÇÐȸ Á¦1ȸ Ç׾Ͽ¬±¸ Çмú´ëȸ

ÁÖÃÖ±â°ü : ´ëÇÑ¿Ü°úÇÐȸ
½ÃÇà±â°ü(ÁöºÎ/°ú) : ´ëÇÑÀ§Àå°ü¿Ü°úÇÐȸ

´ã´çÀÚ : ±èÁÖ¿¬
¿¬¶ôó : 070-8691-1704

À̸ÞÀÏ : ksgis1012@gmail.com

±³À°Á¾·ù : ¿Ü°ú

Âü¼®¿¹»óÀÎ : 80¸í
Èñ¸ÁÆòÁ¡ : 5Á¡

Áö¿ª : °æ±âµµ
±³À°½Ã°£ : 5 ½Ã°£ 40ºÐ

¼¼ºÎ¼ö°­·á : 30,000¿ø  

ºñ°í ȸ¿ø 2¸¸¿ø/ ºñȸ¿ø 3¸¸¿ø


±¸ºÐ ¿ùÀÏ °­ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °­»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 09:30~09:45 Fluoropyrimidines ³²±ÃÀ±(°í·ÁÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 09:45~10:00 Platinums ¹æ°æÇý(Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 10:00~10:15 Taxanes and Others ±èÀçÁØ(ºÎ»êÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 10:15~10:30 Target agents & Immunotherapy ÀÌÈ¿¶ô(¿øÀڷº´¿ø)

Åä·Ð 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 10:30~10:50 Åä·Ð ¹ÎÀç¼® / ±è¼º°ï / ÀÌÀºÁÖ(µ¿³²±Ç¿øÀÚ·ÂÀÇÇпø / °Ç¾çÀÇ´ë / Áß¾ÓÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:10~11:25 Hypersensitivity Reactions and Hematologic Events À̸í¿ø(Ãæ³²ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:25~11:40 Neuropathy and Hand-Foot Syndrome ±èÇüµ·(¿ï»êÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:40~11:55 Gastro-intestinal Events ÀÌÇÏ¿¹¹Î(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 11:55~12:10 QOL after Chemotherapy Treatment and Clinical Trial ¹Ú±â¹ü(°æºÏÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 12:10~12:30 Åä·Ð ±èÀº¿µ / ¹Î»çÈ« / À±»óÀÏ(°¡Å縯ÀÇ´ë / ¿ï»êÀÇ´ë / Ãæ³²ÀÇ´ë)

½Ä»ç 09¿ù 02ÀÏ 5Ãþ Á÷¿ø½Ä´ç 12:30~13:20 Luncheon ()

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 13:20~13:40 Satellite Symposium-Nivolumab for Gastric Cancer ÃÖ¿ø¿µ(±¹¸³¾Ï¼¾ÅÍ)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 13:40~13:55 Review of chemotherapy guidelines for gastric cancer ±èÀÎÈ£(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 13:55~14:10 Response Evaluation Criteria in Solid Tumors (RECIST) ±è¼­¸®(°¡Å縯ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 14:10~14:25 Outpatient Chemotherapy: Benefits, Risks, and Costs Áø¼ºÈ£(¿øÀڷº´¿ø)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 14:25~14:40 Neoadjuvant chemotherapy for gastric cancer ÀåÀ¯Áø(°í·ÁÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 14:40~15:00 Åä·Ð Á¤¹Ì¶õ / À±Á¾Çõ / À̼¼Áø(Àü³²ÀÇ´ë / ¼øõÇâÀÇ´ë / ÀüºÏÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 15:20~15:35 Ascites development during adjuvant chemotherapy ±ÇÀαÔ(¿¬¼¼ÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 15:35~15:50 Complications induced by intraperitoneal chemotherapy ¼­¿øÁØ(°í·ÁÀÇ´ë)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 15:50~16:05 Preoperative chemotherapy for advanced gastric cancer Á¤ÁöÀ±(±¹±º ¾çÁÖº´¿ø)

±³À°½Ã°£ 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 16:05~16:20 Revisional antreflux surgery ±èµ¿¿í(´Ü±¹ÀÇ´ë)

Åä·Ð 09¿ù 02ÀÏ Áß¾Ó´ëÇб³ ±¤¸íº´¿ø 5Ãþ ±èºÎ¼·È¦ 16:20~16:40 Åä·Ð ¿À¼ºÁø / ¼ÛÁ¤È£ / ¹Ú±â¹ü(ÀÎÁ¦ÀÇ´ë / ¾ÆÁÖÀÇ´ë / °¡Å縯ÀÇ´ë)

 

ÆÄ¿ö¸µÅ© ±¤°íµî·Ï
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
¸Þµð¾÷
" ´ëÇÑÀ§Àå°ü¿Ü°úÇÐȸ Á¦1ȸ Ç׾Ͽ¬±¸ Çмú´ëȸ : 2023-09-02""ÀÇ ÀÌ¿ëÈı⳪ Ãßõ´ñ±ÛÀ» ³²°Ü À¯¿ëÇÑ Á¤º¸·Î °øÀ¯ÇսôÙ. ^^
¡å
ÀÌ °Ô½Ã¹°À» ÃßõÇÕ´Ï´Ù.
 
¸ñ·Ï ¼öÁ¤ »èÁ¦
ÀÌÀü±Û 2023³âµµ ´ëÇѼÒÈ­±â¾Ï¿¬±¸ÇÐȸ Á¦2ȸ À¶ÇÕ¿¬±¸¸¦ À§ÇÑ ²Þ³ª¹« À°¼º ÄÝ·ÎÄû¾ö : 2023-09-02
´ÙÀ½±Û ºÐÁöº´º¯¿¬±¸È¸ 2023 KBC(Korean Bifurcation Club) Workshop : 2023-09-02
¹øÈ£ Á¦¸ñ Ãßõ Á¶È¸ µî·ÏÀÏ
21045 ¼­¿ï 2024³â Á¦23ȸ ´ëÇÑôÃ߽űâ¼úÇÐȸ Ãá°è Á¤±âÇмú´ëȸ : 2024-06-29 0 6 2024-06-18
21044 ¼­¿ï (¿Â¶óÀÎ)2024³â »ó¹Ý±â ÀÇ·áºÐÀï ¿¹¹æ ¿¬¼ö±³À° : 2024-06-29 0 9 2024-06-18
21043 ºÎ»ê 2024³â ºÎ¿ï°æ ½½°üÀý ¿¬±¸È¸ ÇÏ°è¿öÅ©¼¥ : 2024-06-29 0 9 2024-06-18
21042 ¼­¿ï ´ëÇѳú½Å°æÀçÈ°ÇÐȸ Á¦10Â÷ °æÁ÷Àü¹®±³À°°úÁ¤ : 2024-06-29 0 13 2024-06-18
21041 ¼­¿ï Çѱ¹¿©¼ºÁ¤½ÅÀÇÇÐȸ ³­¹Î/ÀÌÁֹΠÁ¤½Å°Ç°­ : 2024-06-29 0 7 2024-06-18
21040 °æ±â Á¦12ȸ ÀÎÁ¦ÀÇ´ë ÀÏ»ê¹éº´¿ø ½Å°æ¿Ü°ú ¿¬¼ö°­Á : 2024-06-29 0 4 2024-06-18
21039 ºÎ»ê 2024³â Á¦2ȸ ´ëÇѼҾƺñ´¢ÀÇÇÐȸ Transitional Urology Symposium : 2024-06-29 0 11 2024-06-18
21038 ¼­¿ï 2024³â ´ëÇѳëÀνŰæÀÇÇÐȸ Ãá°èÇмú´ëȸ : 2024-06-29 0 14 2024-06-18
21037 ¼­¿ï Á¦6ȸ °í·Á´ëÇб³ ¾È¾Ïº´¿ø ½Å°æ¿Ü°ú ½ÉÆ÷Áö¾ö : 2024-06-29 0 15 2024-06-18
21036 ¼­¿ï 2024 ´ëÇÑ ¼Ò¾Æ¾Ë·¹¸£±â È£Èí±âÇÐȸ Ãá°èÇмú´ëȸ 2ÀÏÂ÷ : 2024-06-29 0 10 2024-06-18
21035 ¼­¿ï (¿Â¶óÀÎ) 2024³â ´ëÇÑ°øÁߺ¸°ÇÀÇ»çÇùÀÇȸ 3Â÷ ¿Â¶óÀÎ ÇÏ°è Çмú´ëȸ (2ÀÏÂ÷) : 2024-06-28 0 5 2024-06-18
21034 ºÎ»ê Á¦11Â÷ ´ëÇÑ¿µ»óÀÇÇÐȸ Ãá°èÁ¾ÇÕ½ÉÆ÷Áö¾ö 2ÀÏÂ÷ : 2024-06-28 0 6 2024-06-18
21033 Àü³² ´ëÇÑÁ¤Çü¿Ü°úÇÐȸ È£³²Áöȸ - Á¦298Â÷ ¿ù·ÊÁý´ãȸ : 2024-06-28 0 20 2024-06-18
21032 ¼­¿ï 2024 Çѱ¹Á¤½Å½ÅüÀÇÇÐȸ Ãá°èÇмú´ëȸ ¹× ¿¬¼ö±³À° : 2024-06-28 0 8 2024-06-18
21031 ¼­¿ï (2ÀÏÂ÷)2024³â ´ëÇÑô¼öÇÐȸ 2nd ISCoS Regional Symposium : 2024-06-28 0 7 2024-06-18
1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10
 
Ä¿¹Â´ÏƼ
°Ô½ÃÆÇ
°Ç°­Á¤º¸
º´¿ø¾à±¹
Èú¸µ½ºÅ丮
Áúº´Á¤º¸
ÀǾàÇ°Á¤º¸
ÀÇÇм­Àû
ÀÓ´ë¸Å¸Å
¿¬¼ö°­ÁÂ
±³À°Á¤º¸
º´¿øȨÆäÀÌÁö
¸ÞµðÅå
ÇÑÀÇ¿ø
¼ºÇü¿Ü°ú
Ä¡°ú
¾È°ú
¿©¼ºº´¿ø
³»°ú
Á¤Çü¿Ü°ú
ÇǺΰú
¼Ò¾Æ°ú
À̺ñÀÎÈÄ°ú
ºñ´¢ÀÇÇаú
¿ä¾çº´¿ø
ÀçÈ°ÀÇÇаú
µ¿¹°º´¿ø
±âŸº´ÀÇ¿ø
Ãë¾÷°ü·Ã
Áö¿ø¼­¾ç½Ä
¼­·ù¾ç½Ä
¸Þµð¾÷ ¸ð¹ÙÀÏÀ¥
¸Þµð¾÷